Ramat Gan, Israel

Stephan Cherkez

This inventor holds 1 USPTO granted patent. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Cherkez. Retrieved from https://idiyas.com/inventor/stephan-cherkez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephan Cherkez

Introduction

Stephan Cherkez is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work at Teva Pharmaceutical Industries Limited. His expertise and dedication have led to the development of valuable patents that enhance medical science.

Latest Patents

One of Stephan Cherkez's key patents is the preparation of 4(5)-hydroxymethyl-5(4)-methylimidazole. This compound, known as MHI, is prepared through a specific process that involves several steps. His work in this area demonstrates his commitment to advancing pharmaceutical research and development.

Career Highlights

Throughout his career, Stephan has focused on creating solutions that address complex challenges in the pharmaceutical industry. His role at Teva Pharmaceutical Industries Limited has allowed him to collaborate with other talented professionals and contribute to groundbreaking research.

Collaborations

Stephan has worked alongside esteemed colleagues such as Ben Z Weiner and Abraham Antebi. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of new pharmaceutical products.

Conclusion

Stephan Cherkez's contributions to the field of pharmaceuticals through his patents and collaborations highlight his importance as an inventor. His work continues to impact the industry positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…